Tau Oligomers as Potential Targets for Immunotherapy for Alzheimer's Disease and Tauopathies

E-ISSN： 1875-5828|8|6|659-665

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.8, Iss.6, 2011-09, pp. : 659-665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 217-228

Bentham Science Publishers

Access to resources Recommend Favorite

Tau in Alzheimer Disease and Related Tauopathies

Current Alzheimer Research, Vol. 7, Iss. 8, 2010-12 ,pp. : 656-664

Bentham Science Publishers

Access to resources Recommend Favorite

Tau-Focused Immunotherapy for Alzheimer's Disease and Related Tauopathies

Current Alzheimer Research, Vol. 6, Iss. 5, 2009-10 ,pp. : 446-450

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies

By Irwin David J.

Brain, Vol. 135, Iss. 3, 2012-04 ,pp. : 807-818

Oxford University Press

Access to resources Recommend Favorite

Mechanism of Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies

Current Alzheimer Research, Vol. 5, Iss. 4, 2008-08 ,pp. : 375-384

Bentham Science Publishers

Access to resources Recommend Favorite